Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Lung Neoplasms 5Smoking Cessation 2Colorectal Neoplasms 2Solitary Pulmonary Nodule 1Pulmonary Disease, Chronic Obstructive 1Neoplasms 1Neoplasm, Residual 1Motor Activity 1Inflammation 1Disease 1Cardiovascular Diseases 1

Interventions

Bevacizumab 56Cetuximab 50Fluorouracil 45Leucovorin 39Oxaliplatin 38pembrolizumab 31Specimen Handling 27Irinotecan 25Magnetic Resonance Spectroscopy 17Biopsy 17Nivolumab 15HMPL-013 13Folfox protocol 13Capecitabine 13Gemcitabine 12Cisplatin 12trifluridine tipiracil drug combination 11Panitumumab 11Carboplatin 11Pemetrexed 9IFL protocol 9encorafenib 8balstilimab 8Standard of Care 8Paclitaxel 8Early Intervention, Educational 8130-nm albumin-bound paclitaxel 8fludarabine 7atezolizumab 7Educational Status 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Colorectal Neoplasms × Hematologic Tests × 90 days × Clear all
NCT06929481 2026-05-28

Screening With a DNA Blood Test to Address Colorectal Cancer Inequities

University of California, San Diego

Phase NA Active not recruiting
340 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT07090291 2026-04-14

China Colorectal Cancer Screening Trial 1 (C-Cost1)

Zhejiang University

Phase NA Recruiting
60,300 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡